EA

Ejaz Ahmad Rabbani

Active Director Director DIN 09047543
DIN 09047543 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Ejaz Ahmad Rabbani

Data last updated:

Ejaz Ahmad Rabbani is a Director at Cardimes Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Cardimes Pharmaceuticals Private Limited reported revenue of ₹1.64 Cr (FY 2025).

DIN 09047543
Primary Designation Director
Industry Trading
First Appointment 01 Feb 2021
Oldest Company Age 5 yrs
Largest company Cardimes Pharmaceuticals Private Limited · ₹1.64 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20212021₹1.64 Cr (FY 2025)Active

Board colleagues of Ejaz Ahmad Rabbani

Directorship timeline

Open interactive timeline →
Cardimes Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ejaz Ahmad Rabbani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ejaz Ahmad Rabbani

Ejaz Ahmad Rabbani currently holds 1 directorship: Cardimes Pharmaceuticals Private Limited (Director, since 01 Feb 2021, revenue ₹1.64 Cr (FY 2025)).

Ejaz Ahmad Rabbani was first appointed on 01 Feb 2021 as Director at Cardimes Pharmaceuticals Private Limited.

The current boards of Ejaz Ahmad Rabbani's companies include Hafsa Khatoon (Cardimes Pharmaceuticals Private Limited), Md Mohsin Hashmi (Cardimes Pharmaceuticals Private Limited), Mohammad Shakir (Cardimes Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available